vs
Ubiquiti Inc.（UI）与West Pharmaceutical Services（WST）财务数据对比。点击上方公司名可切换其他公司
Ubiquiti Inc.的季度营收约是West Pharmaceutical Services的1.0倍（$814.9M vs $805.0M），Ubiquiti Inc.净利率更高（28.7% vs 16.4%，领先12.3%），Ubiquiti Inc.同比增速更快（35.8% vs 7.5%），Ubiquiti Inc.自由现金流更多（$260.3M vs $175.0M），过去两年Ubiquiti Inc.的营收复合增速更高（28.6% vs 7.6%）
Ubiquiti Inc.是一家美国科技企业，2003年于加利福尼亚州圣何塞成立，目前总部位于纽约。公司旗下拥有多个品牌，主营面向企业及家庭用户的有线、无线数据通信产品的研发、生产与销售。
美国West Pharmaceutical Services是注射用药品包装及给药系统的设计和制造商，1923年成立，总部位于宾夕法尼亚州埃克斯顿。成立初期主营注射类药物包装用橡胶组件，曾为青霉素和胰岛素生产商提供符合无菌要求的配套产品。
UI vs WST — 直观对比
营收规模更大
UI
是对方的1.0倍
$805.0M
营收增速更快
UI
高出28.3%
7.5%
净利率更高
UI
高出12.3%
16.4%
自由现金流更多
UI
多$85.3M
$175.0M
两年增速更快
UI
近两年复合增速
7.6%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $814.9M | $805.0M |
| 净利润 | $233.6M | $132.1M |
| 毛利率 | 45.9% | 37.8% |
| 营业利润率 | 35.9% | 19.5% |
| 净利率 | 28.7% | 16.4% |
| 营收同比 | 35.8% | 7.5% |
| 净利润同比 | 70.8% | 1.5% |
| 每股收益（稀释后） | $3.86 | $1.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收UIWST
| Q4 25 | $814.9M | $805.0M | ||
| Q3 25 | $733.8M | $804.6M | ||
| Q2 25 | $759.2M | $766.5M | ||
| Q1 25 | $664.2M | $698.0M | ||
| Q4 24 | $599.9M | $748.8M | ||
| Q3 24 | $550.3M | $746.9M | ||
| Q2 24 | $507.5M | $702.1M | ||
| Q1 24 | $493.0M | $695.4M |
净利润UIWST
| Q4 25 | $233.6M | $132.1M | ||
| Q3 25 | $207.9M | $140.0M | ||
| Q2 25 | $266.7M | $131.8M | ||
| Q1 25 | $180.4M | $89.8M | ||
| Q4 24 | $136.8M | $130.1M | ||
| Q3 24 | $128.0M | $136.0M | ||
| Q2 24 | $103.8M | $111.3M | ||
| Q1 24 | $76.3M | $115.3M |
毛利率UIWST
| Q4 25 | 45.9% | 37.8% | ||
| Q3 25 | 46.0% | 36.6% | ||
| Q2 25 | 45.1% | 35.7% | ||
| Q1 25 | 44.5% | 33.2% | ||
| Q4 24 | 41.2% | 36.5% | ||
| Q3 24 | 42.1% | 35.4% | ||
| Q2 24 | 40.2% | 32.8% | ||
| Q1 24 | 35.3% | 33.1% |
营业利润率UIWST
| Q4 25 | 35.9% | 19.5% | ||
| Q3 25 | 35.7% | 20.8% | ||
| Q2 25 | 34.4% | 20.1% | ||
| Q1 25 | 34.2% | 15.3% | ||
| Q4 24 | 29.8% | 21.3% | ||
| Q3 24 | 30.7% | 21.6% | ||
| Q2 24 | 27.3% | 18.0% | ||
| Q1 24 | 22.6% | 17.7% |
净利率UIWST
| Q4 25 | 28.7% | 16.4% | ||
| Q3 25 | 28.3% | 17.4% | ||
| Q2 25 | 35.1% | 17.2% | ||
| Q1 25 | 27.2% | 12.9% | ||
| Q4 24 | 22.8% | 17.4% | ||
| Q3 24 | 23.3% | 18.2% | ||
| Q2 24 | 20.5% | 15.9% | ||
| Q1 24 | 15.5% | 16.6% |
每股收益（稀释后）UIWST
| Q4 25 | $3.86 | $1.82 | ||
| Q3 25 | $3.43 | $1.92 | ||
| Q2 25 | $4.40 | $1.82 | ||
| Q1 25 | $2.98 | $1.23 | ||
| Q4 24 | $2.26 | $1.78 | ||
| Q3 24 | $2.12 | $1.85 | ||
| Q2 24 | $1.72 | $1.51 | ||
| Q1 24 | $1.26 | $1.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $302.8M | $791.3M |
| 总债务越低越好 | $47.5M | $202.8M |
| 股东权益账面价值 | $1.0B | $3.2B |
| 总资产 | $1.6B | $4.3B |
| 负债/权益比越低杠杆越低 | 0.05× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资UIWST
| Q4 25 | $302.8M | $791.3M | ||
| Q3 25 | $177.2M | $628.5M | ||
| Q2 25 | $149.7M | $509.7M | ||
| Q1 25 | $151.0M | $404.2M | ||
| Q4 24 | $133.1M | $484.6M | ||
| Q3 24 | $165.2M | $490.9M | ||
| Q2 24 | $126.3M | $446.2M | ||
| Q1 24 | $102.5M | $601.8M |
总债务UIWST
| Q4 25 | $47.5M | $202.8M | ||
| Q3 25 | $133.8M | $202.7M | ||
| Q2 25 | $250.0M | $202.6M | ||
| Q1 25 | $340.0M | $202.6M | ||
| Q4 24 | $406.3M | $202.6M | ||
| Q3 24 | $552.5M | $202.6M | ||
| Q2 24 | $708.1M | $205.8M | ||
| Q1 24 | $877.5M | $206.2M |
股东权益UIWST
| Q4 25 | $1.0B | $3.2B | ||
| Q3 25 | $828.4M | $3.1B | ||
| Q2 25 | $668.3M | $2.9B | ||
| Q1 25 | $436.1M | $2.7B | ||
| Q4 24 | $290.4M | $2.7B | ||
| Q3 24 | $188.1M | $2.8B | ||
| Q2 24 | $95.1M | $2.6B | ||
| Q1 24 | $25.9M | $2.7B |
总资产UIWST
| Q4 25 | $1.6B | $4.3B | ||
| Q3 25 | $1.5B | $4.1B | ||
| Q2 25 | $1.5B | $4.0B | ||
| Q1 25 | $1.3B | $3.6B | ||
| Q4 24 | $1.2B | $3.6B | ||
| Q3 24 | $1.2B | $3.7B | ||
| Q2 24 | $1.2B | $3.5B | ||
| Q1 24 | $1.2B | $3.6B |
负债/权益比UIWST
| Q4 25 | 0.05× | 0.06× | ||
| Q3 25 | 0.16× | 0.07× | ||
| Q2 25 | 0.37× | 0.07× | ||
| Q1 25 | 0.78× | 0.08× | ||
| Q4 24 | 1.40× | 0.08× | ||
| Q3 24 | 2.94× | 0.07× | ||
| Q2 24 | 7.45× | 0.08× | ||
| Q1 24 | 33.92× | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $263.9M | $251.1M |
| 自由现金流经营现金流 - 资本支出 | $260.3M | $175.0M |
| 自由现金流率自由现金流/营收 | 31.9% | 21.7% |
| 资本支出强度资本支出/营收 | 0.4% | 9.5% |
| 现金转化率经营现金流/净利润 | 1.13× | 1.90× |
| 过去12个月自由现金流最近4个季度 | $699.5M | $468.9M |
8季度趋势，按日历期对齐
经营现金流UIWST
| Q4 25 | $263.9M | $251.1M | ||
| Q3 25 | $198.5M | $197.2M | ||
| Q2 25 | $130.4M | $177.1M | ||
| Q1 25 | $123.6M | $129.4M | ||
| Q4 24 | $152.4M | $190.1M | ||
| Q3 24 | $233.7M | $180.1M | ||
| Q2 24 | $231.4M | $165.0M | ||
| Q1 24 | $163.9M | $118.2M |
自由现金流UIWST
| Q4 25 | $260.3M | $175.0M | ||
| Q3 25 | $193.3M | $133.9M | ||
| Q2 25 | $125.2M | $101.9M | ||
| Q1 25 | $120.7M | $58.1M | ||
| Q4 24 | $150.4M | $85.2M | ||
| Q3 24 | $231.1M | $98.8M | ||
| Q2 24 | $229.5M | $64.8M | ||
| Q1 24 | $160.6M | $27.6M |
自由现金流率UIWST
| Q4 25 | 31.9% | 21.7% | ||
| Q3 25 | 26.3% | 16.6% | ||
| Q2 25 | 16.5% | 13.3% | ||
| Q1 25 | 18.2% | 8.3% | ||
| Q4 24 | 25.1% | 11.4% | ||
| Q3 24 | 42.0% | 13.2% | ||
| Q2 24 | 45.2% | 9.2% | ||
| Q1 24 | 32.6% | 4.0% |
资本支出强度UIWST
| Q4 25 | 0.4% | 9.5% | ||
| Q3 25 | 0.7% | 7.9% | ||
| Q2 25 | 0.7% | 9.8% | ||
| Q1 25 | 0.4% | 10.2% | ||
| Q4 24 | 0.3% | 14.0% | ||
| Q3 24 | 0.5% | 10.9% | ||
| Q2 24 | 0.4% | 14.3% | ||
| Q1 24 | 0.7% | 13.0% |
现金转化率UIWST
| Q4 25 | 1.13× | 1.90× | ||
| Q3 25 | 0.95× | 1.41× | ||
| Q2 25 | 0.49× | 1.34× | ||
| Q1 25 | 0.68× | 1.44× | ||
| Q4 24 | 1.11× | 1.46× | ||
| Q3 24 | 1.83× | 1.32× | ||
| Q2 24 | 2.23× | 1.48× | ||
| Q1 24 | 2.15× | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
UI
| Enterprise Technology | $729.0M | 89% |
| Service Provider Technology | $85.9M | 11% |
WST
| Proprietary Products | $661.8M | 82% |
| Contract Manufactured Products | $143.2M | 18% |
| Affiliated Entity | $3.3M | 0% |
